Compounds > nsc 664704

nsc 664704 and 2-[(3-iodophenyl)methylthio]-5-pyridin-4-yl-1,3,4-oxadiazole

nsc 664704 has been researched along with 2-[(3-iodophenyl)methylthio]-5-pyridin-4-yl-1,3,4-oxadiazole in 4 studies

Research

Studies (4)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	2 (50.00)	29.6817
2010's	2 (50.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Flajolet, M; Greengard, P; Meijer, L	1
Bullock, AN; Fedorov, O; Knapp, S; Marsden, B; Müller, S; Pogacic, V; Rellos, P; Schwaller, J; Sundström, M	1
Augustin, M; Davies, SP; Gao, Y; Harvey, KJ; Kovelman, R; Patel, UA; Woodward, A	1
Arrat, H; Lukas, TJ; Scheidt, K; Schiltz, GE; Siddique, T	1

Reviews

1 review(s) available for nsc 664704 and 2-[(3-iodophenyl)methylthio]-5-pyridin-4-yl-1,3,4-oxadiazole

Article	Year
Pharmacological inhibitors of glycogen synthase kinase 3. Trends in pharmacological sciences, 2004, Volume: 25, Issue:9 Topics: Animals; Cell Differentiation; Diabetes Mellitus, Type 2; Enzyme Inhibitors; Glycogen Synthase Kinase 3; Humans; Neoplasms; Nervous System Diseases; Parasitic Diseases; Signal Transduction; Stem Cells; Structure-Activity Relationship	2004

Other Studies

3 other study(ies) available for nsc 664704 and 2-[(3-iodophenyl)methylthio]-5-pyridin-4-yl-1,3,4-oxadiazole

Article	Year
A systematic interaction map of validated kinase inhibitors with Ser/Thr kinases. Proceedings of the National Academy of Sciences of the United States of America, 2007, Dec-18, Volume: 104, Issue:51 Topics: Amino Acid Sequence; Binding Sites; Clinical Trials as Topic; Drug Evaluation, Preclinical; Enzyme Stability; Humans; Molecular Sequence Data; Phylogeny; Protein Array Analysis; Protein Conformation; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases	2007
A broad activity screen in support of a chemogenomic map for kinase signalling research and drug discovery. The Biochemical journal, 2013, Apr-15, Volume: 451, Issue:2 Topics: Aurora Kinases; Cluster Analysis; Drug Design; Drug Discovery; Drug Evaluation, Preclinical; ErbB Receptors; Humans; Intracellular Signaling Peptides and Proteins; MAP Kinase Kinase 4; p38 Mitogen-Activated Protein Kinases; Protein Kinase Inhibitors; Protein Kinases; Protein Serine-Threonine Kinases; Protein-Tyrosine Kinases; Receptors, Vascular Endothelial Growth Factor; Recombinant Proteins; Reproducibility of Results; Signal Transduction; Small Molecule Libraries; Structure-Activity Relationship; Syk Kinase	2013
Discovery of 1,3,4-oxidiazole scaffold compounds as inhibitors of superoxide dismutase expression. Bioorganic & medicinal chemistry letters, 2014, Mar-15, Volume: 24, Issue:6 Topics: Animals; Cell Line; Drug Evaluation, Preclinical; Gene Expression Regulation; Mice; Oxadiazoles; Small Molecule Libraries; Structure-Activity Relationship; Superoxide Dismutase	2014